T. Rowe Price Investment Management Inc. lifted its stake in shares of Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 13.3% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,744,714 shares of the company's stock after purchasing an additional 439,722 shares during the quarter. T. Rowe Price Investment Management Inc. owned about 1.24% of Stevanato Group worth $76,468,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Whittier Trust Co. acquired a new position in Stevanato Group during the first quarter valued at $27,000. Johnson Financial Group Inc. bought a new position in shares of Stevanato Group during the 4th quarter worth approximately $41,000. Van Berkom & Associates Inc. lifted its position in Stevanato Group by 33.3% during the 1st quarter. Van Berkom & Associates Inc. now owns 2,400 shares of the company's stock worth $49,000 after buying an additional 600 shares in the last quarter. Wells Fargo & Company MN raised its stake in shares of Stevanato Group by 680.3% in the fourth quarter. Wells Fargo & Company MN now owns 3,246 shares of the company's stock worth $71,000 after acquiring an additional 2,830 shares during the last quarter. Finally, Tower Research Capital LLC TRC raised its stake in shares of Stevanato Group by 202.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,413 shares of the company's stock worth $162,000 after acquiring an additional 4,965 shares during the last quarter.
Stevanato Group Trading Up 4.0%
NYSE:STVN traded up €0.90 on Thursday, reaching €23.30. The company's stock had a trading volume of 206,063 shares, compared to its average volume of 336,133. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.22 and a current ratio of 1.79. The business's 50-day moving average price is €24.22 and its two-hundred day moving average price is €22.49. Stevanato Group S.p.A. has a 1-year low of €17.12 and a 1-year high of €28.00. The firm has a market cap of $7.06 billion, a PE ratio of 43.15, a PEG ratio of 2.04 and a beta of 0.55.
Wall Street Analyst Weigh In
Separately, William Blair reissued an "outperform" rating on shares of Stevanato Group in a research note on Monday, June 30th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy".
Get Our Latest Report on Stevanato Group
About Stevanato Group
(
Free Report)
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Featured Articles

Before you consider Stevanato Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.
While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.